Project Medtech

In this episode, Devon and I discuss building a successful team, fractionalizing vs. full time, cultural red flags, and more. Prodct Website Devon Campbell LinkedIn

 In this episode, Devon and I discuss his background in medical device & diagnostics, how he founded Prodct, the voice of the customer, and who really is VOC throughout product development. Prodct Website Devon Campbell LinkedIn

In this episode, Maxwell and I discuss the Da Vinci Academy, starting a business as a resident, networking in the field of medicine, using entrepreneurship to share and develop ideas, and more.   Maxwell Cooper Bio: Dr. Cooper earned B.A. and M.S. degrees from Case Western Reserve University and his M.D. from the University of Toledo College of Medicine, and currently is a Radiology resident at Emory University. He also co-founded and runs a medical education company called DaVinci Academy that he started during medical school DaVinci Academy provides online video courses and outline format textbooks for medical students. In addition, Dr. Cooper recently started and hosts a podcast called The DaVinci Hour, presented by DaVinci Academy.   Maxwell Cooper, M.D. LinkedIn: https://www.linkedin.com/in/maxwellcoopermd Twitter: https://twitter.com/mcoopermd DaVinci Academy Website: https://www.dviacademy.com/ Linkedin: https://www.linkedin.com/company/davinci-academy---dviacademy.com The DaVinci Hour Podcast Website: https://www.dviacademy.com/the-davinci-hour

In this episode, Bob, Greg and I discuss AiM Medical Robotics, advice for start-up companies, where the robotic industry is going, and more.  Bob Cathcart: Bob is an experienced Medical Device executive, with over 30 years in the industry.   He has extensive General Management experience, having led both large and small companies.  Most recently, Bob was CEO of Clear Guide Medical, a start-up company focused on novel approaches to Image Guided Surgery.  Of note, Bob was Senior Vice President of World Wide Sales for Hansen Medical, the leader in Surgical Robotics for the Cardiovascular space.  He was part of the senior executive team that led the sale of Hansen Medical to Auris Robotics, which was eventually purchased by JNJ in 2019.  Greg Fischer: Greg is the William Smith Dean's Professor and a faculty member in Robotics Engineering with  appointments in Mechanical Engineering and Biomedical Engineering at WPI. He received his PhD in Mechanical Engineering in 2008 from Johns Hopkins University, where he was part of the NSF Engineering Research Center for Computer Integrated Surgery. At WPI he has been an integral part of developing the Robotics Engineering program and teaches primarily junior-level and graduate courses in Robotics. He is the founding director of the Automation and Interventional Medicine (AIM) Robotics Research Laboratory. He is also the Director of the MassTech-supported PracticePoint R&D Center for translational research in healthcare cyber-physical systems.  AiM Medical Robotics PracticePoint R&D Center

In this episode, Neil and I discuss seed to series A financing, advice for start-up companies, the medtech scene in Cleveland, the importance of cap tables, and more. 

In this episode, Zeke and I discuss SMMG MedTech, his history in selling medical devices, advice and pitfalls of selling a medical device product and more.   Bio: Zeke Zielinski is the Founder and President of SMMG MedTech. Zeke is a MedTech Sales Executive with over 25 years of experience in start-up, mid-size, and large-cap medical device companies including CR Bard, ACS (Eli Lily), Heart Technology, and Boston Scientific. He has also led sales organizations in early-stage startups such as CoAxia, Interrad Medical, Angiotech, LifeWatch AngioScore, and Spectranetics. He is currently the Sales Director with Abbott Vascular. He resides in Mound, Minnesota and is a graduate of Purdue University.

In   this episode, Tim and I discuss fractionalizing your team as a start-up, how   to do it, a companies first full time hire and more.

In this episode, Zed, Clark and I discuss TrackableMed, selling medical technology, advice to building your commercial team, pitfals and more. 

In this episode, Dvir, Jan and I discuss Memic, robotic surgery, how to evaluate an unmet clinical need, how they chose their first market, fundraising tips and more.  Bio: Dvir Cohen has served as Chief Executive Officer at Memic since October 2013. Mr. Cohen has been a leader in the Company from its inception and also serves as a president of our U.S. subsidiary, Memic Innovative Surgery Inc. Mr. Cohen brings more than 15 years of experience in innovative robotic systems. Prior to joining the Company, Mr. Cohen served in various positions in the Israeli Ministry of Defense as an awarded officer specializing in robotic systems for various applications. From 2011 to 2013, Mr. Cohen held the positions of research and development manager and robotic project specialist in an elite technology unit of the Israel Intelligence Force. From 2007 to 2011, Mr. Cohen led several opto-mechanical disruptive solutions in the Ministry of Defense, one of which won the Israel Defense Award. Mr. Cohen has experience at all stages of product development, from the early conceptual stage through prototyping to production line implementation and final market. Mr. Cohen earned an M.B.A in 2013 from the Recanati Business School at Tel Aviv University with a major in Business Strategy and Entrepreneurship. He also earned B.Sc. and M.Sc. degrees in Mechanical Engineering from the Technion as part of the “Brakim” excellence program in 2007.   Prof. Dr. Jan Baekelandt is currently a consultant for the Department of Gynaecological Oncology and Endoscopy at Imelda Hospital in Bonheiden, Belgium. He is guest professor at the University of Leuven, department of development and regeneration in urogenital abdominal and plastic surgery. He specializes in gynecological oncology, and robotic and endoscopic surgery. Dr. Baekelandt qualified as a Medical Doctor (1999) and specialist in Gynecology and Obstetrics (2004) at the Catholic University of Leuven, Belgium. He subspecialized as a gynecological oncologist (2004-2006) in Pretoria, South Africa and Köln, Germany. He is a pioneer in the emerging field of Natural Orifice Surgery and has written his PhD on transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES), of which he has performed over 1500 cases. He introduced vNOTES in Europe, developed the technique of total vaginal NOTES hysterectomy and of vaginal retroperitoneal sentinel node dissection. He also introduced transvaginal robotic surgery as part of his PhD research.

In this episode, Mike and I discuss his new blog post about the 10 risks life science companies will face in 2021.   Mike Cremeans Bio: He leads the Life Sciences Practice for Hylant, whose mission is to strengthen the businesses, employees and communities of our client family by embracing them as our own. He is a client facing risk strategist and recognized subject matter expert for Life Sciences related products and services and partner with his customers to identify, simplify and translate complicated risks/situations into understandable concepts and practical solutions.